Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

Androgen use may increase the risk of stroke, but more research is needed.

These new skin treatments are safer and more effective with minimal side effects.

The bio-based complex effectively repairs and protects chemically damaged hair.

Certain medications can cause gum problems, so patients and healthcare providers should be aware and monitor oral health.

Integrating biological networks improves drug repurposing and ADR prediction.

Bacterial cellulose is a promising material for biomedical uses but needs improvements in antimicrobial properties and degradation rate.

Microalgae can sustainably improve nutrition and cosmetics with their diverse beneficial compounds.

LLLT devices for hair loss need more research to define proper guidelines.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

A new acne cream effectively reduced acne in trials and awaits FDA approval.

Pranlukast and mirabegron may work as new diabetes drugs.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Finasteride has a higher risk of reproductive side effects than minoxidil.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Laser hair transplantation can be effective but should be limited to small areas and requires more training to ensure safety and effectiveness.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

The study explored a possible link between finasteride use and suicide.

Public interest in finasteride's sexual side effects has significantly increased.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.